Improved monitoring of 2-Hydroxyglutarate to stage response of combined Vorasidenib and Tumor Specific Peptide Vaccine therapies in recurrent IDH1 mutant lower grade glioma
Administered By
Awarded By
Contributors
- Archer, Gerald Edward Collaborator
- Barboriak, Daniel P. Investigator
- Peters, Katherine Barnett Co-Principal Investigator
- Soher, Brian Joseph Principal Investigator
Start/End
- September 21, 2022 - August 31, 2026